相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacogenetics of Drug Metabolizing Enzymes and Transporters: Effects on Pharmacokinetics and Pharmacodynamics of Anticancer Agents
Norman H. Lee
Anti-Cancer Agents in Medicinal Chemistry (2011)
Frequencies of Single-Nucleotide Polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 Genes in a Finnish Population
Alli Laitinen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Perspectives on Epigenetics and Its Relevance to Adverse Drug Reactions
M. Kacevska et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Organic Anion Transporting Polypeptides (OATPs): Regulation of Expression and Function
Martin Svoboda et al.
CURRENT DRUG METABOLISM (2011)
Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease
April D. Lake et al.
DRUG METABOLISM AND DISPOSITION (2011)
Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease
Rhiannon N. Hardwick et al.
DRUG METABOLISM AND DISPOSITION (2011)
Pharmacogenomics and adverse drug reactions: the case of statins
Mariano A. Giorgi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Ming Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression
Heather Pressler et al.
PLOS ONE (2011)
The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans
Junko Imanaga et al.
PHARMACOGENETICS AND GENOMICS (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
Progress in the Genetics of Primary Biliary Cirrhosis
Gideon M. Hirschfield et al.
SEMINARS IN LIVER DISEASE (2011)
The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA
S-M Huang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
DNA Methylation Profiles of Organic Anion Transporting Polypeptide 1B3 in Cancer Cell Lines
Sayaka Ichihara et al.
PHARMACEUTICAL RESEARCH (2010)
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Curtis D. Klaassen et al.
PHARMACOLOGICAL REVIEWS (2010)
Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci
Eric R. Gamazon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hepatocellular Carcinoma: Hepatocyte-selective Enhancement at Gadoxetic Acid-enhanced MR Imaging-Correlation with Expression of Sinusoidal and Canalicular Transporters and Bile Accumulation
Takahiro Tsuboyama et al.
RADIOLOGY (2010)
Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters
Simone Leuthold et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Impact of OATP transporters on pharmacokinetics
A. Kalliokoski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism
Yi-Jing He et al.
CLINICA CHIMICA ACTA (2009)
Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats
Craig D. Fisher et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
Lisa R. Trevin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The SLCO1B1*5 Genetic Variant Is Associated With Statin-Induced Side Effects
Deepak Voora et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Analysis of DNA Methylation and Histone Modification Profiles of Liver-Specific Transporters
Satoki Imai et al.
MOLECULAR PHARMACOLOGY (2009)
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Emma C. Davies et al.
PLOS ONE (2009)
Regulation of Prostaglandin Transporters in Colorectal Neoplasia
Vijaykumar R. Holla et al.
CANCER PREVENTION RESEARCH (2008)
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in Caucasian patients with androgen-independent prostatic cancer
Akinobu Hamada et al.
CLINICAL CANCER RESEARCH (2008)
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
Roger K. Verbeeck
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide
Annikka Kalliokoski et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Global analysis of genetic variation in SLCOIB1
Marja K. Pasanen et al.
PHARMACOGENOMICS (2008)
Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney
Zoulikha M. Zaier et al.
PHARMACOGENOMICS (2008)
Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family
B. Hagenbuch et al.
XENOBIOTICA (2008)
Obstructive cholestasis induces TNF-α- and IL-1β-mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2
Markus G. Donner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants
Richard H. Ho et al.
PHARMACOGENETICS AND GENOMICS (2007)
GI Epidemiology: nonalcoholic fatty liver disease
P. Angulo
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice
D. G. Bailey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Intestinal drug transporter expression and the impact of grapefruit juice in humans
H. Glaeser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Differential regulation of hepatic transporters in the absence of tumor necrosis factor-α, interleukin-1β, interleukin-6, and nuclear factor-κB in two models of cholestasis
Andrew J. Lickteig et al.
DRUG METABOLISM AND DISPOSITION (2007)
Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells
Noel R. Monks et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Variants in the SLCO1B3 gene: Interethnic distribution and association with paclitaxel pharmacokinetics
N. F. Smith et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Marja K. Pasanen et al.
PHARMACOGENETICS AND GENOMICS (2006)
Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liver
Antonin Libra et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Drug-drug interaction between pitavastatin and various drugs via OATP1B1
Masaru Hirano et al.
DRUG METABOLISM AND DISPOSITION (2006)
Effects of organic anion transporting polypeptide IBI haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril
Kazuya Maeda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
R Kerb
CANCER LETTERS (2006)
Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps)
XG Cheng et al.
DRUG METABOLISM AND DISPOSITION (2005)
Hepatobiliary transporter expression in human hepatocellular carcinoma
G Zollner et al.
LIVER INTERNATIONAL (2005)
Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers
C Planchamp et al.
INVESTIGATIVE RADIOLOGY (2005)
Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2) - Implications for altered drug disposition and central nervous system drug entry
W Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Drug therapy in the heart transplant recipient - Part IV: Drug-drug interactions
RL Page et al.
CIRCULATION (2005)
Drug therapy in the heart transplant recipient - Part III: Common medical problems
J Lindenfeld et al.
CIRCULATION (2005)
Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, or inducible nitric oxide synthase
N Li et al.
TOXICOLOGICAL SCIENCES (2005)
Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the rat
A Treiber et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3β in hepatocellular carcinoma
SR Vavricka et al.
JOURNAL OF HEPATOLOGY (2004)
Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human
T Nozawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Organic anion transporting polypeptides of the OATP/SLC21 family:: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties
B Hagenbuch et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8)
K Letschert et al.
PHARMACOGENETICS (2004)
Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats
NJ Cherrington et al.
DRUG METABOLISM AND DISPOSITION (2004)
Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression
M Hedman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Identification of steroid sulfate transport processes in the human mammary gland
F Pizzagalli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane
D Kobayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Detection of the human organic anion transporters SLUM (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma
YH Cui et al.
LABORATORY INVESTIGATION (2003)
Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A
Y Shitara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Comparative inhibitory effects of different compounds on rat Oatp1 (Slc21a1)- and Oatp2 (Slc21a5)-mediated transport
Y Shitara et al.
PHARMACEUTICAL RESEARCH (2002)
FDA adverse event reports on statin-associated rhabdomyolysis
MA Omar et al.
ANNALS OF PHARMACOTHERAPY (2002)
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine
GK Dresser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus
N Ichimaru et al.
ATHEROSCLEROSIS (2001)
Polymorphisms in OATP-C -: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
RG Tirona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family
I Tamai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
